Showing results (41-50 of 85) with videos related to
Sort By:
Pageof 9
British Journal of Haematology|May 2, 2023
Sustained response off treatment in eltrombopag for children with persistent/chronic primary immune thrombocytopenia: A multicentre observational retrospective study in ChinaZhifa Wang, Lijuan Wang, Yan Liu, et al.British Journal of Haematology|July 6, 2026
Plasma metabolomics profile alterations in the onset and progression of paediatric immune thrombocytopeniaTong Zou, Juntao Ouyang, Zheyan Lin, et al.European Journal of Pediatrics|May 28, 2021
Increased proportion of Th17/Treg cells at the new diagnosed stage of chronic immune thrombocytopenia in pediatrics: the pilot study from a multi-centerHao Gu, Zhenping Chen, Xiaodong Shi, et al.Annals of Hematology|January 24, 2025
The impact of Mycoplasma pneumoniae infection on platelets in children with immune thrombocytopenia: a real-world study from ChinaNan Wang, Zhifa Wang, Juntao Ouyang, et al.British Journal of Haematology|January 5, 2025
Long-term efficacy and safety of avatrombopag in Chinese children with primary immune thrombocytopenia: A real-world observational studyNan Wang, Zhifa Wang, Jingjing Liu, et al.Biorxiv : the Preprint Server for Biology|December 18, 2023
Machine Learning Elucidates Design Features of Plasmid DNA Lipid Nanoparticles for Cell Type-Preferential TransfectionLeonardo Cheng, Yining Zhu, Jingyao Ma, et al.British Journal of Haematology|August 9, 2025
Urine proteomics uncovers biomarker candidates for early identifying rituximab beneficiaries in paediatric steroid-resistant immune thrombocytopeniaYuncui Yu, Xingjuan Xie, Zhenping Chen, et al.ACS Nano|October 7, 2024
Machine Learning Elucidates Design Features of Plasmid Deoxyribonucleic Acid Lipid Nanoparticles for Cell Type-Preferential TransfectionLeonardo Cheng, Yining Zhu, Jingyao Ma, et al.Biorxiv : the Preprint Server for Biology|April 17, 2026
Cell-nanoplastics association impacts cell proliferation and motilityQin Ni, Jingyao Ma, Jinyu Fu, et al.ACS Applied Materials & Interfaces|February 2, 2026
Class II Peptide-Major Histocompatibility Complex Lipid Nanoparticles Enable in vivo mRNA Delivery to Antigen-Specific CD4<sup>+</sup> T CellsJoseph Choy, Leonardo Cheng, Milan Patel, et al.Pageof 9